DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

296.74 -3.40 (-1.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $296.74 -1.13%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $300.45
Previous Close $300.14
Daily Range $296.02 - $304.96
52-Week Range $203.70 - $352.49
Market Cap $29.7B
P/E Ratio 77.88
Dividend (Yield) $0.00 (0.0%)
Volume 607,221
Average Daily Volume 1,293,793
Current FY EPS $4.37

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner

Nasdaq 100 Movers: LLTC, YHOO

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipe

UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipeline Success

3 Stocks Reiterated As A Hold: TSLA, PM, REGN

New Stock Coverage: Use (Don't Lose) Your Head in Regeneron

Wall Street ratings agencies set the tone for today's stock market.

Benzinga's Top Initiations

Good News for BioMarin - Analyst Blog

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Is the robust IPO market affecting the broader indices?

Nasdaq 100 Movers: ISRG, REGN

See More REGN News...

REGN's Top Competitors

REGN $296.74 (-1.13%)
Current stock: REGN
AMGN $115.46 (-0.07%)
Current stock: AMGN
GILD $70.00 (1.04%)
Current stock: GILD
BIIB $290.54 (-0.32%)
Current stock: BIIB